|SEND TO PRINTER|
Feature Articles : May 1, 2008 ( )
Search Continues for Injection Alternatives
Companies Are Actively Seeking Solutions that Will Increase Patient Compliance
Most biopharmaceutical drugs cannot, at present, be taken orally. Since patients do not like injections, there is a need for new ways to deliver medications. More effective delivery systems also offer big pharma increased opportunities to create new products at a time when many blockbusters are coming off patents and competition from biosimilars is looming.
Supercritical Fluid Technology
There are two ways in which companies can use advances in drug delivery to continuously improve and differentiate their products from the competition, said Joel Richard, Ph.D., head of pharmaceutical development for biotech products at Merck-Serono.
Delivering medicines to the eye poses an interesting challenge, which OphthalmoPharma (OPPH) was founded to address.
© 2012 Genetic Engineering & Biotechnology News, All Rights Reserved